BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15829309)

  • 21. [HLA-G1 molecule expressed by ECV304 cells inhibit cytotoxic activity of allogeneic NK cells].
    Zhang CE; Han JY; Yang HJ; Wu XW; Huang YF; Liang ZH; Gong FL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):676-8. PubMed ID: 16256023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
    Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
    J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porcine aortic endothelial cells transfected with HLA-G are partially protected from xenogeneic human NK cytotoxicity.
    Forte P; Matter-Reissmann UB; Strasser M; Schneider MK; Seebach JD
    Hum Immunol; 2000 Nov; 61(11):1066-73. PubMed ID: 11137209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
    Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets.
    Llano M; Gumá M; Ortega M; Angulo A; López-Botet M
    Eur J Immunol; 2003 Oct; 33(10):2744-54. PubMed ID: 14515258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal epithelial cells modulating HLA class I surface molecules are susceptible to lysis mediated by CD3(+) and CD3(-) "nonspecific" killer cells.
    Semino C; Pietra G; Semino A; Falco M; Varaldo M; Melioli G
    Cell Immunol; 1998 Dec; 190(2):183-90. PubMed ID: 9878119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells.
    Chumbley G; King A; Robertson K; Holmes N; Loke YW
    Cell Immunol; 1994 May; 155(2):312-22. PubMed ID: 8181068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.
    de Matos CT; Berg L; Michaëlsson J; Felländer-Tsai L; Kärre K; Söderström K
    Immunology; 2007 Oct; 122(2):291-301. PubMed ID: 17521371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An in vitro coculture model to study cytokine profiles of natural killer cells during maternal immune cell-trophoblast interactions.
    Ntrivalas E; Kwak-Kim J; Beaman K; Mantouvalos H; Gilman-Sachs A
    J Soc Gynecol Investig; 2006 Apr; 13(3):196-202. PubMed ID: 16516503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of HLA-G boosted natural killer cell-mediated cytolysis in JEG-3 cells cultured in vitro.
    Sun LL; Han Y; Chen JH; Yao YQ
    Fertil Steril; 2008 Dec; 90(6):2398-405. PubMed ID: 18243178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rapid induction of HLA-E is essential for the survival of antigen-activated naive CD4 T cells from attack by NK cells.
    Takao S; Ishikawa T; Yamashita K; Uchiyama T
    J Immunol; 2010 Nov; 185(10):6031-40. PubMed ID: 20952676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors.
    Peña J; Alonso C; Solana R; Serrano R; Carracedo J; Ramirez R
    Eur J Immunol; 1990 Nov; 20(11):2445-8. PubMed ID: 1701392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
    Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J
    Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
    Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
    J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-E expression on porcine cells: protection from human NK cytotoxicity depends on peptide loading.
    Forte P; Baumann BC; Weiss EH; Seebach JD
    Am J Transplant; 2005 Sep; 5(9):2085-93. PubMed ID: 16095487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
    Zhang C; Tian Z; Hou G
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell.
    Lesport E; Baudhuin J; LeMaoult J; Sousa S; Doliger C; Carosella ED; Favier B
    Hum Immunol; 2009 Dec; 70(12):1000-5. PubMed ID: 19654030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis.
    Matsunami K; Miyagawa S; Nakai R; Yamada M; Shirakura R
    Transplantation; 2002 May; 73(10):1582-9. PubMed ID: 12042643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.